HIV-1 Molecular Epidemiology Laboratory, Department of Microbiology and Parasitology, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Universitario Ramón y Cajal, CIBER en Epidemiología y Salud Pública (CIBERESP), Red en Investigación Translacional en Infecciones Pediátricas (RITIP), Madrid, Spain.
AIDS Res Hum Retroviruses. 2021 Oct;37(10):793-795. doi: 10.1089/AID.2020.0180. Epub 2021 Mar 17.
HIV variants carry natural polymorphisms related to drug resistance (R-markers) fixed during viral evolution in the absence of antiretroviral therapy (ART) that may impact on drug susceptibility and resistance pathways. We aimed to identify the HIV type 2 (HIV-2) variant-specific R-markers at Pol in all available sequences from ART-naive subjects deposited in Los Alamos database according to reported HIV-2 drug resistance-associated mutations (DRMs) and report the performance of two online HIV-2 resistance interpretation tools (HIV2EU Tool and Stanford HIVdb Program for HIV-2) to detect them. From a total of 587 sequences, we found 23 R-markers in low frequency, in groups A, B, and G. Four were present in >10% of the sequences with no direct impact on antiretroviral susceptibility. HIV2EU Tool detected one, whereas Stanford program all four. Stanford new tool, although still under development, seems effective in detecting HIV-2 DRMs and may prove a useful tool for HIV-2 resistance interpretation when fully developed.
HIV 变体携带与耐药性相关的自然多态性(R 标记),这些多态性是在没有抗逆转录病毒治疗(ART)的情况下病毒进化过程中固定的,可能影响药物敏感性和耐药途径。我们旨在根据报告的 HIV-2 耐药相关突变(DRMs),在 Los Alamos 数据库中所有来自未经 ART 治疗的受试者的可用 HIV-2 序列中识别 Pol 上的 HIV-2 变体特异性 R 标记,并报告两种在线 HIV-2 耐药性解释工具(HIV2EU Tool 和斯坦福 HIVdb Program for HIV-2)的性能,以检测它们。在总共 587 个序列中,我们在 A、B 和 G 组中发现了 23 个低频 R 标记。其中 4 个存在于超过 10%的序列中,对抗逆转录病毒敏感性没有直接影响。HIV2EU Tool 检测到 1 个,而斯坦福程序则检测到所有 4 个。斯坦福新工具虽然仍在开发中,但在检测 HIV-2 DRMs 方面似乎很有效,当它完全开发出来时,可能会成为 HIV-2 耐药性解释的有用工具。